• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精准医学时代用于活性分子脉冲式和结肠递送的Chronotopic™系统:通过熔融沉积建模(FDM)3D打印实现的可行性

The Chronotopic™ System for Pulsatile and Colonic Delivery of Active Molecules in the Era of Precision Medicine: Feasibility by 3D Printing via Fused Deposition Modeling (FDM).

作者信息

Melocchi Alice, Uboldi Marco, Briatico-Vangosa Francesco, Moutaharrik Saliha, Cerea Matteo, Foppoli Anastasia, Maroni Alessandra, Palugan Luca, Zema Lucia, Gazzaniga Andrea

机构信息

Sezione di Tecnologia e Legislazione Farmaceutiche "M. E. Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, 20133 Milan, Italy.

Dipartimento di Chimica, Materiali e Ingegneria Chimica "G. Natta", Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy.

出版信息

Pharmaceutics. 2021 May 20;13(5):759. doi: 10.3390/pharmaceutics13050759.

DOI:10.3390/pharmaceutics13050759
PMID:34065414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8161275/
Abstract

The pulsatile-release Chronotopic™ system was conceived of as a drug-containing core surrounded by a coat made of swellable/soluble hydrophilic polymers, the latter being able to provide a programmable lag phase prior to drug liberation. This system was also proposed in a colon-targeting configuration, entailing a gastroresistant film to prevent early interaction of the inner coat with gastric fluids and enabling the attainment of a lag phase matching the small intestinal transit time. Over the years, various multiple-step manufacturing processes have been tested for the fabrication of the Chronotopic™ system in both its configurations. This work focused on the evaluation of 3D printing by fused deposition modeling in view of its potential towards product personalization, on demand one-step manufacturing and efficient scale down of batches. The feasibility of each part of the Chronotopic™ system was independently investigated starting from in-house made filaments, characterizing the resulting specimens for physico-technological and performance characteristics. The printing parameters identified as suitable during the set-up phase were then used to fabricate prototypes either in a single step for the pulsatile configuration or following two different fabrication approaches for the colon-targeting one.

摘要

脉冲释放的Chronotopic™系统的设计理念是,药物核心被一层由可膨胀/可溶解的亲水性聚合物制成的包衣所包围,后者能够在药物释放之前提供一个可编程的延迟期。该系统还被设计成结肠靶向剂型,需要一层抗胃膜,以防止内层包衣与胃液过早相互作用,并实现与小肠转运时间相匹配的延迟期。多年来,已经对各种多步制造工艺进行了测试,以制造两种构型的Chronotopic™系统。鉴于其在产品个性化、按需一步制造和有效缩小批次规模方面的潜力,这项工作重点评估了熔融沉积建模3D打印技术。从自制长丝开始,独立研究了Chronotopic™系统各部分的可行性,并对所得样品的物理技术和性能特征进行了表征。然后,在设置阶段确定为合适的打印参数被用于一步制造脉冲构型的原型,或采用两种不同的制造方法制造结肠靶向构型的原型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/03f97471b659/pharmaceutics-13-00759-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/2d9af690db64/pharmaceutics-13-00759-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/9a3916d1776a/pharmaceutics-13-00759-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/8cc427c77f0c/pharmaceutics-13-00759-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/89c7b648ea36/pharmaceutics-13-00759-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/89905dcb5922/pharmaceutics-13-00759-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/e34051f9b80a/pharmaceutics-13-00759-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/03f97471b659/pharmaceutics-13-00759-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/2d9af690db64/pharmaceutics-13-00759-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/9a3916d1776a/pharmaceutics-13-00759-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/8cc427c77f0c/pharmaceutics-13-00759-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/89c7b648ea36/pharmaceutics-13-00759-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/89905dcb5922/pharmaceutics-13-00759-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/e34051f9b80a/pharmaceutics-13-00759-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a432/8161275/03f97471b659/pharmaceutics-13-00759-g007.jpg

相似文献

1
The Chronotopic™ System for Pulsatile and Colonic Delivery of Active Molecules in the Era of Precision Medicine: Feasibility by 3D Printing via Fused Deposition Modeling (FDM).精准医学时代用于活性分子脉冲式和结肠递送的Chronotopic™系统:通过熔融沉积建模(FDM)3D打印实现的可行性
Pharmaceutics. 2021 May 20;13(5):759. doi: 10.3390/pharmaceutics13050759.
2
Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.基于药用级聚合物的热熔挤出长丝,用于通过熔融沉积建模进行3D打印。
Int J Pharm. 2016 Jul 25;509(1-2):255-263. doi: 10.1016/j.ijpharm.2016.05.036. Epub 2016 May 20.
3
3D printing by fused deposition modeling of single- and multi-compartment hollow systems for oral delivery - A review.熔融沉积成型法制备单腔和多腔中空系统用于口服递药的 3D 打印技术:综述。
Int J Pharm. 2020 Apr 15;579:119155. doi: 10.1016/j.ijpharm.2020.119155. Epub 2020 Feb 17.
4
3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.药物的3D打印:设计具有独特设计和药物释放特性的新型口服制剂。
Mol Pharm. 2015 Nov 2;12(11):4077-84. doi: 10.1021/acs.molpharmaceut.5b00510. Epub 2015 Oct 16.
5
Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.熔融沉积建模的快速药物释放 3D 打印片剂的配方:用于药物释放、药物-聚合物混溶性和可印刷性筛选的聚合物。
J Pharm Sci. 2018 Jan;107(1):390-401. doi: 10.1016/j.xphs.2017.10.021. Epub 2017 Oct 21.
6
Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing.通过桌面(FDM)3D 打印技术制备布地奈德控释片。
Int J Pharm. 2015 Dec 30;496(2):414-20. doi: 10.1016/j.ijpharm.2015.10.039. Epub 2015 Oct 19.
7
Application of Fused Deposition Modelling (FDM) Method of 3D Printing in Drug Delivery.3D打印的熔融沉积建模(FDM)方法在药物递送中的应用。
Curr Pharm Des. 2017;23(3):433-439. doi: 10.2174/1381612822666161026162707.
8
An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.一项关于使用聚合物共混物来改善通过熔融沉积建模(FDM)3D打印制备的药物固体分散体的可印刷性并调节其药物释放的研究。
Eur J Pharm Biopharm. 2016 Nov;108:111-125. doi: 10.1016/j.ejpb.2016.08.016. Epub 2016 Sep 2.
9
Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.热敏药物的低温熔融沉积成型(FDM)3D 打印。
Int J Pharm. 2018 Jul 10;545(1-2):144-152. doi: 10.1016/j.ijpharm.2018.04.055. Epub 2018 Apr 26.
10
Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.熔融沉积成型 3D 打印方法的简化:一步直接粉末打印用于即时释放剂型生产的可行性。
Int J Pharm. 2020 Mar 30;578:119124. doi: 10.1016/j.ijpharm.2020.119124. Epub 2020 Feb 5.

引用本文的文献

1
3D printing processes in precise drug delivery for personalized medicine.3D 打印在精准药物输送中的应用——个性化医疗的新途径。
Biofabrication. 2024 Apr 17;16(3). doi: 10.1088/1758-5090/ad3a14.
2
Chrono-tailored drug delivery systems: recent advances and future directions.时间定制药物传递系统:最新进展和未来方向。
Drug Deliv Transl Res. 2024 Jul;14(7):1756-1775. doi: 10.1007/s13346-024-01539-4. Epub 2024 Feb 28.
3
Drug-Eluting Sutures by Hot-Melt Extrusion: Current Trends and Future Potentials.热熔挤压法制备的药物洗脱缝线:当前趋势与未来潜力

本文引用的文献

1
Shape memory materials and 4D printing in pharmaceutics.形状记忆材料与药剂学的 4D 打印
Adv Drug Deliv Rev. 2021 Jun;173:216-237. doi: 10.1016/j.addr.2021.03.013. Epub 2021 Mar 25.
2
Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines.熔融沉积成型(FDM),定制药物生产的新资产。
J Control Release. 2021 Feb 10;330:821-841. doi: 10.1016/j.jconrel.2020.10.056. Epub 2020 Oct 29.
3
Quality considerations on the pharmaceutical applications of fused deposition modeling 3D printing.熔融沉积成型 3D 打印在药物应用方面的质量考虑因素。
Materials (Basel). 2023 Nov 20;16(22):7245. doi: 10.3390/ma16227245.
4
Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications.在非生物复杂药物制造中利用制药4.0技术:创新与影响
Pharmaceutics. 2023 Oct 28;15(11):2545. doi: 10.3390/pharmaceutics15112545.
5
Insights into the Safety and Versatility of 4D Printed Intravesical Drug Delivery Systems.4D打印膀胱内给药系统的安全性与多功能性洞察
Pharmaceutics. 2023 Feb 24;15(3):757. doi: 10.3390/pharmaceutics15030757.
6
Investigation on the use of fused deposition modeling for the production of IR dosage forms containing Timapiprant.关于使用熔融沉积成型法生产含替马普仑的红外剂型的研究。
Int J Pharm X. 2022 Dec 24;5:100152. doi: 10.1016/j.ijpx.2022.100152. eCollection 2023 Dec.
7
Expandable Drug Delivery Systems Based on Shape Memory Polymers: Impact of Film Coating on Mechanical Properties and Release and Recovery Performance.基于形状记忆聚合物的可膨胀药物递送系统:薄膜包衣对机械性能、释放及恢复性能的影响
Pharmaceutics. 2022 Dec 15;14(12):2814. doi: 10.3390/pharmaceutics14122814.
8
Perspectives of colon-specific drug delivery in the management of morning symptoms of rheumatoid arthritis.结肠特异性药物递送在类风湿关节炎晨症管理中的应用前景
Inflammopharmacology. 2023 Feb;31(1):253-264. doi: 10.1007/s10787-022-01120-w. Epub 2022 Dec 21.
9
Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament-Investigation of Materials, Process, and Product Characteristics.省略对材料、工艺和产品特性进行长丝研究的药物3D打印新方法。
Pharmaceutics. 2022 Nov 17;14(11):2488. doi: 10.3390/pharmaceutics14112488.
10
3D Printed Fractal-like Structures with High Percentage of Drug for Zero-Order Colonic Release.用于零级结肠释放的含高药物百分比的3D打印类分形结构
Pharmaceutics. 2022 Oct 26;14(11):2298. doi: 10.3390/pharmaceutics14112298.
Int J Pharm. 2021 Jan 5;592:119901. doi: 10.1016/j.ijpharm.2020.119901. Epub 2020 Oct 1.
4
A Graphical Review on the Escalation of Fused Deposition Modeling (FDM) 3D Printing in the Pharmaceutical Field.图形化综述:热熔沉积成型(FDM)3D 打印在制药领域的发展历程。
J Pharm Sci. 2020 Oct;109(10):2943-2957. doi: 10.1016/j.xphs.2020.07.011. Epub 2020 Jul 15.
5
Evaluation of powder-layering vs. spray-coating techniques in the manufacturing of a swellable/erodible pulsatile delivery system.粉末层积法与喷雾包衣法在可溶胀/蚀性脉冲释放给药系统制备中的评价。
Drug Dev Ind Pharm. 2020 Aug;46(8):1230-1237. doi: 10.1080/03639045.2020.1788060. Epub 2020 Jul 7.
6
Erodible coatings based on HPMC and cellulase for oral time-controlled release of drugs.基于 HPMC 和纤维素酶的可蚀涂层用于口服药物的时间控制释放。
Int J Pharm. 2020 Jul 30;585:119425. doi: 10.1016/j.ijpharm.2020.119425. Epub 2020 May 28.
7
Injection Molded Capsules for Colon Delivery Combining Time-Controlled and Enzyme-Triggered Approaches.用于结肠递药的注塑胶囊,结合了时控和酶触发两种方法。
Int J Mol Sci. 2020 Mar 11;21(6):1917. doi: 10.3390/ijms21061917.
8
Lego-Inspired Capsular Devices for the Development of Personalized Dietary Supplements: Proof of Concept With Multimodal Release of Caffeine.受乐高启发的胶囊装置,用于开发个性化膳食补充剂:以多模式释放咖啡因为例的概念验证。
J Pharm Sci. 2020 Jun;109(6):1990-1999. doi: 10.1016/j.xphs.2020.02.013. Epub 2020 Feb 27.
9
3D printing by fused deposition modeling of single- and multi-compartment hollow systems for oral delivery - A review.熔融沉积成型法制备单腔和多腔中空系统用于口服递药的 3D 打印技术:综述。
Int J Pharm. 2020 Apr 15;579:119155. doi: 10.1016/j.ijpharm.2020.119155. Epub 2020 Feb 17.
10
In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic release.口服 5-ASA 结肠递释系统的体外和人体药物闪烁显像评估。
Int J Pharm. 2019 Dec 15;572:118723. doi: 10.1016/j.ijpharm.2019.118723. Epub 2019 Oct 16.